Donat, Sherri

Publications

Sort by

Co-Author Network

selected publications

The impact of fluid optimisation before induction of anaesthesia on hypotension after induction. Anaesthesia. 2020 Academic Article GET IT
Times cited: 17
Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes. European urology. 2018 Academic Article GET IT
Times cited: 173
Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2018 Academic Article GET IT
Times cited: 94
Commentary: Does Asymptomatic Bacteriuria Reduce the Risk of Recurrence of Non-muscle-invasive Bladder Tumors?. Urology. 2016 Academic Article GET IT
Times cited: 6
A cost-effectiveness analysis of management of low-risk non-muscle-invasive bladder cancer using office-based fulguration. Urology. 2015 Academic Article GET IT
Times cited: 24
Reply: To PMID 25623694. Urology. 2015 Comment GET IT
Adherence to surveillance guidelines after radical cystectomy: a population-based analysis. Urologic oncology. 2014 Academic Article GET IT
Times cited: 10
Preoperative serum albumin is associated with mortality and complications after radical cystectomy. BJU international. 2014 Academic Article GET IT
Times cited: 72
Gender disparities in hematuria evaluation and bladder cancer diagnosis: a population based analysis. The Journal of urology. 2014 Academic Article GET IT
Times cited: 66
Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder. The Journal of urology. 2014 Academic Article GET IT
Times cited: 59
A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy. Brachytherapy. 2013 Academic Article GET IT
Times cited: 97
Upper tract imaging surveillance is not effective in diagnosing upper tract recurrence in patients followed for nonmuscle invasive bladder cancer. The Journal of urology. 2013 Academic Article GET IT
Times cited: 32
Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline. 2013 GET IT
Times cited: 229
Intravesical gemcitabine for high risk, nonmuscle invasive bladder cancer after bacillus Calmette-Guérin treatment failure. The Journal of urology. 2013 Academic Article GET IT
Times cited: 35
Pathological response to neoadjuvant chemotherapy for muscle-invasive micropapillary bladder cancer. BJU international. 2013 Academic Article GET IT
Times cited: 71
Urinary diversion practice patterns among certifying American urologists. The Journal of urology. 2012 Academic Article GET IT
Times cited: 13
12th Annual meeting of the Society of Urologic Oncology (SUO) bladder cancer sessions I and II summary report. Urologic oncology. 2012 Conference Paper GET IT
Times cited: 3
Assessment of complication and functional outcome reporting in the minimally invasive prostatectomy literature from 2006 to the present. BJU international. 2011 Review GET IT
Times cited: 16
Evaluating the utility of a preoperative nomogram for predicting 90-day mortality following radical cystectomy for bladder cancer. BJU international. 2011 Academic Article GET IT
Times cited: 23
A plea for a uniform surveillance schedule after radical cystectomy. The Journal of urology. 2011 Academic Article GET IT
Times cited: 11
Bacillus Calmette-Guérin without maintenance therapy for high-risk non-muscle-invasive bladder cancer. European urology. 2011 Academic Article GET IT
Times cited: 60
Editorial comment. Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder. Urology. 2011 Editorial Article GET IT
Variability of treatment selection among surgeons for patients with cT1 urothelial carcinoma. BJU international. 2010 Academic Article GET IT
Times cited: 13
Assessing urological complications of radiation therapy and surgical approaches for repair. The Journal of urology. 2010 Editorial Article GET IT
Times cited: 1
Reduced bladder tumour recurrence rate associated with narrow-band imaging surveillance cystoscopy. BJU international. 2010 Academic Article GET IT
Times cited: 68
Clinical outcomes of primary bladder carcinoma in situ in a contemporary series. The Journal of urology. 2010 Academic Article GET IT
Times cited: 46
Clinical outcome of primary versus secondary bladder carcinoma in situ. The Journal of urology. 2010 Academic Article GET IT
Times cited: 34
Radical cystectomy in octogenarians--does morbidity outweigh the potential survival benefits?. The Journal of urology. 2010 Academic Article GET IT
Times cited: 114
Editorial comment. Urology. 2010 Editorial Article GET IT
Complications after radical and partial nephrectomy as a function of age. The Journal of urology. 2010 Academic Article GET IT
Times cited: 64
Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer. The Journal of urology. 2010 Academic Article GET IT
Times cited: 22
Editorial comment. The Journal of urology. 2010 Editorial Article GET IT
Analysis of gender differences in early perioperative complications following radical cystectomy at a tertiary cancer center using a standardized reporting methodology. Urologic oncology. 2010 Academic Article GET IT
Times cited: 32
Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer. European urology. 2009 Academic Article GET IT
Times cited: 107
Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies. BJU international. 2009 Academic Article GET IT
Times cited: 71
Integrating perioperative chemotherapy into the treatment of muscle-invasive bladder cancer: strategy versus reality. Journal of the National Comprehensive Cancer Network : JNCCN. 2009 Review GET IT
Times cited: 33
A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience. Cancer. 2008 Academic Article GET IT
Times cited: 219
Placement of transileal conduit retrograde nephroureteral stents in patients with ureteral obstruction after cystectomy: technique and outcome. AJR. American journal of roentgenology. 2008 Academic Article GET IT
Times cited: 17
Quality control in transurethral resection of bladder tumours. BJU international. 2008 Academic Article GET IT
Times cited: 168
A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences. BJU international. 2008 Academic Article GET IT
Times cited: 149
Argument against frozen section analysis of distal ureters in transitional cell bladder cancer. Nature clinical practice. Urology. 2008 Review GET IT
Times cited: 17
Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. European urology. 2008 Academic Article GET IT
Times cited: 1043
Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience. European urology. 2008 Academic Article GET IT
Times cited: 192
Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer. 2008 Academic Article GET IT
Times cited: 241
Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance. The Journal of urology. 2007 Academic Article GET IT
Times cited: 73
Elisabeth Pauline Pickett (1918-): opening the door for women in urological oncology. The Journal of urology. 2007 Article GET IT
Times cited: 12
Management of low grade papillary bladder tumors. The Journal of urology. 2007 Academic Article GET IT
Times cited: 103
Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy. European urology. 2007 Academic Article GET IT
Times cited: 89
Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer. The Journal of urology. 2007 Academic Article GET IT
Times cited: 132
Urinary diversion: options, patient selection, and outcomes. Seminars in oncology. 2007 Review GET IT
Times cited: 30
Use of urinary biomarkers for bladder cancer surveillance: patient perspectives. The Journal of urology. 2007 Academic Article GET IT
Times cited: 66
Defining optimal therapy for muscle invasive bladder cancer. The Journal of urology. 2007 Review GET IT
Times cited: 180
Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract. Urology. 2007 Academic Article GET IT
Times cited: 60
Standards for surgical complication reporting in urologic oncology: time for a change. Urology. 2007 Review GET IT
Times cited: 176
Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?. The Journal of urology. 2007 Academic Article GET IT
Times cited: 123
Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer. Urology. 2007 Review GET IT
Times cited: 164
Natural history of positive urinary cytology after radical cystectomy. The Journal of urology. 2006 Academic Article GET IT
Times cited: 20
Perioperative clinical thromboembolic events after radical or partial nephrectomy. Urology. 2006 Academic Article GET IT
Times cited: 25
Significance of intraoperative ureteral evaluation at radical cystectomy for urothelial cancer. Cancer. 2006 Academic Article GET IT
Times cited: 64
Staged based directed surveillance of invasive bladder cancer following radical cystectomy: valuable and effective?. World journal of urology. 2006 Review GET IT
Times cited: 21
Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients. The Journal of urology. 2006 Academic Article GET IT
Times cited: 47
Formulas calculating creatinine clearance are inadequate for determining eligibility for Cisplatin-based chemotherapy in bladder cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Academic Article GET IT
Times cited: 63
Association between urinary cytology and pathology for nontransitional cell malignancies of the urinary tract. The Journal of urology. 2006 Academic Article GET IT
Times cited: 6
Clinical characteristics of bladder cancer in patients previously treated with radiation for prostate cancer. BJU international. 2006 Academic Article GET IT
Times cited: 46
A re-staging transurethral resection predicts early progression of superficial bladder cancer. BJU international. 2006 Academic Article GET IT
Times cited: 96
Impact of body mass index on survival of patients with surgically treated renal cell carcinoma. The Journal of urology. 2006 Academic Article GET IT
Times cited: 84
Does body mass index affect survival of patients undergoing radical or partial cystectomy for bladder cancer?. The Journal of urology. 2005 Academic Article GET IT
Times cited: 56
Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma. The Journal of urology. 2004 Academic Article GET IT
Times cited: 84
Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection. The Journal of urology. 2004 Academic Article GET IT
Times cited: 114
Efficacy of office fulguration for recurrent low grade papillary bladder tumors less than 0.5 cm. The Journal of urology. 2004 Academic Article GET IT
Times cited: 72
Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study. The Journal of urology. 2004 Academic Article GET IT
Times cited: 83
Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer. Cancer immunity. 2003 Academic Article GET IT
Times cited: 67
Evaluation and follow-up strategies for superficial bladder cancer. The Urologic clinics of North America. 2003 Review GET IT
Times cited: 100
Fluid intake and the risk of tumor recurrence in patients with superficial bladder cancer. The Journal of urology. 2003 Academic Article GET IT
Times cited: 15
Orthotopic urinary diversion after cystectomy for bladder cancer: implications for cancer control and patterns of disease recurrence. The Journal of urology. 2003 Academic Article GET IT
Times cited: 103
Correlation of cystoscopy with histology of recurrent papillary tumors of the bladder. The Journal of urology. 2002 Academic Article GET IT
Times cited: 71
Early nasogastric tube removal combined with metoclopramide after postchemotherapy retroperitoneal lymph node dissection for metastatic testicular nonseminomatous germ cell tumor. Urology. 2002 Academic Article GET IT
Times cited: 8
Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. The Journal of urology. 2002 Academic Article GET IT
Times cited: 521
The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer. The Journal of urology. 2001 Academic Article GET IT
Times cited: 73
Mechanisms of prostatic stromal invasion in patients with bladder cancer: clinical significance. The Journal of urology. 2001 Academic Article GET IT
Times cited: 63
Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer. The Journal of urology. 2001 Academic Article GET IT
Times cited: 140
MRI of vaginal leiomyomas. 2001 GET IT
Times cited: 35
Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy. The Journal of urology. 2001 Academic Article GET IT
Times cited: 163
Magnetic resonance imaging and magnetic resonance angiography before postchemotherapy retroperitoneal lymph node dissection. Urology. 2000 Academic Article GET IT
Times cited: 6
Peri-operative care in patients treated for testicular cancer. Seminars in surgical oncology. 1999 Review GET IT
Times cited: 9
Early nasogastric tube removal combined with metoclopramide after radical cystectomy and urinary diversion. The Journal of urology. 1999 Academic Article GET IT
Times cited: 72
Bleomycin associated pulmonary toxicity: is perioperative oxygen restriction necessary?. The Journal of urology. 1998 Academic Article GET IT
Times cited: 90
Methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and cystectomy for unresectable bladder cancer. The Journal of urology. 1996 Academic Article GET IT
Times cited: 52
Ureteral decompression in advanced nonurologic malignancies. Annals of surgical oncology. 1996 Academic Article GET IT
Times cited: 51
Bladder preservation and continent urinary diversion in T3b transitional cell carcinoma of the bladder. Seminars in urologic oncology. 1996 Review GET IT
Times cited: 3
Reversal by transferrin of growth-inhibitory effect of suramin on hormone-refractory human prostate cancer cells. Journal of the National Cancer Institute. 1995 Academic Article GET IT
Times cited: 14
Salvage radical prostatectomy in the management of locally recurrent prostate cancer after 125I implantation. British journal of urology. 1995 Academic Article GET IT
Times cited: 41
Intrathoracic kidney: a case report with a review of the world literature. The Journal of urology. 1988 Review GET IT
Times cited: 85

more ...

less ...

Background

education and training

M.D., University of Oklahoma College of Medicine 1987
B.S., University of Oklahoma 1980

Contact

full name

Sherri Donat

VIVO Weill Cornell Medical College

Sherri Donat Professor of Urology

Publications

selected publications

Background

education and training

Contact

full name